AstraZeneca plc: PharmaVitae Profile
Buy Now : Market Research
Introduction
This analysis examines the historical and forecast performance for AstraZeneca in the Rx pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.
AstraZeneca plc: PharmaVitae Profile
Reasons to Purchase
- Benchmark AstraZeneca’s performance against key rivals in the prescription pharmaceutical sector
- Assess the commercial impact of AstraZeneca’s recent movement into the biologics market, spearheaded by its acquisition of MedImmune
- Analyse the exposure of AstraZeneca’s blockbuster portfolio to patent expiration and generic competition through to 2014
Related Reports
- AstraZeneca PLC: SWOT Analysis & Company Profile
- GlaxoSmithKline plc: PharmaVitae Profile
- Shire plc: PharmaVitae Profile
- Warner-Chilcott Plc: PharmaVitae Profile
- AstraZeneca PLC Market Share Analysis
- AstraZeneca PLC – SWOT Analysis
- AstraZeneca Plc-Therapeutic Competitors
- AstraZeneca Plc-Detailed Product Pipeline
- AstraZeneca plc-Deals & Alliances Report
- AstraZeneca PLC (AZN) – Financial and Strategic SWOT Analysis Review
